Ahmet Demirkazık

3.4k total citations
54 papers, 408 citations indexed

About

Ahmet Demirkazık is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ahmet Demirkazık has authored 54 papers receiving a total of 408 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 12 papers in Molecular Biology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ahmet Demirkazık's work include Cancer Treatment and Pharmacology (8 papers), Blood groups and transfusion (5 papers) and Viral-associated cancers and disorders (4 papers). Ahmet Demirkazık is often cited by papers focused on Cancer Treatment and Pharmacology (8 papers), Blood groups and transfusion (5 papers) and Viral-associated cancers and disorders (4 papers). Ahmet Demirkazık collaborates with scholars based in Türkiye, United States and Iran. Ahmet Demirkazık's co-authors include Hakan Akbulut, Fikri İçlı, Bülent Yalçın, Güngör Utkan, Dìlek Dìnçol, Abdullah Büyükçelik, Güngör Utkan, Filiz Çay Şenler, Mutlu Doğan and Abdurrahman Işıkdoğan and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and British Journal of Cancer.

In The Last Decade

Ahmet Demirkazık

50 papers receiving 397 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ahmet Demirkazık Türkiye 11 204 79 71 70 68 54 408
Bicky Thapa United States 13 244 1.2× 89 1.1× 28 0.4× 101 1.4× 91 1.3× 51 441
Claudia Rudroff Germany 14 129 0.6× 81 1.0× 80 1.1× 125 1.8× 58 0.9× 25 450
Kelley A. Barney United States 4 214 1.0× 173 2.2× 94 1.3× 104 1.5× 122 1.8× 5 479
Konstantin Schlick Austria 15 255 1.3× 111 1.4× 74 1.0× 106 1.5× 83 1.2× 35 526
Patrícia Moretto Canada 12 183 0.9× 25 0.3× 37 0.5× 137 2.0× 76 1.1× 18 472
Mandeep S. Dhami United States 3 302 1.5× 65 0.8× 25 0.4× 34 0.5× 39 0.6× 5 387
Scott Marshall United Kingdom 11 135 0.7× 141 1.8× 17 0.2× 73 1.0× 46 0.7× 32 468
Abraham Klepfish Israel 12 151 0.7× 129 1.6× 25 0.4× 63 0.9× 41 0.6× 21 486
Elena Pérez‐Ceballos Spain 13 107 0.5× 236 3.0× 35 0.5× 63 0.9× 63 0.9× 25 578
Feras Abu Saadeh Ireland 11 73 0.4× 71 0.9× 110 1.5× 115 1.6× 46 0.7× 41 483

Countries citing papers authored by Ahmet Demirkazık

Since Specialization
Citations

This map shows the geographic impact of Ahmet Demirkazık's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ahmet Demirkazık with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ahmet Demirkazık more than expected).

Fields of papers citing papers by Ahmet Demirkazık

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ahmet Demirkazık. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ahmet Demirkazık. The network helps show where Ahmet Demirkazık may publish in the future.

Co-authorship network of co-authors of Ahmet Demirkazık

This figure shows the co-authorship network connecting the top 25 collaborators of Ahmet Demirkazık. A scholar is included among the top collaborators of Ahmet Demirkazık based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ahmet Demirkazık. Ahmet Demirkazık is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yekedüz, Emre, Filiz Çay Şenler, Güngör Utkan, et al.. (2023). Impact of antihistamine use on the survival outcomes of immune checkpoint inhibitors in advanced cancer patients. Anti-Cancer Drugs. 35(2). 190–194. 4 indexed citations
2.
Yekedüz, Emre, Filiz Çay Şenler, Güngör Utkan, et al.. (2022). Chronic hyperglycemia based on diabetes is independently associated with decreased survival in patients with advanced cancer treated with immune checkpoint inhibitors. Anti-Cancer Drugs. 33(10). 1145–1149. 5 indexed citations
3.
Yazıcı, Ozan, Mutlu Doğan, Ahmet Demirkazık, et al.. (2020). Osteopontin is a Prognostic Factor in Patients with Advanced Gastric Cancer. Combinatorial Chemistry & High Throughput Screening. 24(8). 1229–1235. 6 indexed citations
4.
Alkan, Ali, Filiz Çay Şenler, Ahmet Demirkazık, et al.. (2017). Vaccination in oncology practice and predictors. Supportive Care in Cancer. 25(9). 2677–2682. 6 indexed citations
5.
Alkan, Ali, et al.. (2016). Thyroid follicular carcinoma complicating with skin metastasis. SHILAP Revista de lepidopterología. 2(2-3). 82–83. 1 indexed citations
6.
Doğan, Mutlu, et al.. (2015). Molecular Spectrum of PIK3CA Gene Mutations in Patients with Nonsmall-Cell Lung Cancer in Turkey. Genetic Testing and Molecular Biomarkers. 19(7). 353–358. 4 indexed citations
7.
Ürün, Yüksel, Duygu Kankaya, Bülent Yalçın, et al.. (2013). Intraabdominal follicular dendritic cell sarcoma: a report of three cases and review of the literature.. PubMed. 99(2). e65–9. 4 indexed citations
8.
Utkan, Güngör, Kadri Altundağ, Osman Şevki Arslan, et al.. (2012). ABO and Rh blood groups frequency in women with HER2 positive breast cancer.. PubMed. 17(3). 457–60. 6 indexed citations
9.
Demirkazık, Ahmet, et al.. (2010). Kanserde Bireyselleştirilmiş Tedavi: Neden Farmakogenetik?. Turkiye Klinikleri Tip Bilimleri Dergisi. 30(3). 1–4.
10.
Gümüş‐Akay, Güvem, Atilla Halil Elhan, Ali Ekrem Ünal, et al.. (2009). Effects of Genomic Imbalances on Telomerase Activity in Gastric Cancer: Clues to Telomerase Regulation. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 17(10). 455–462. 3 indexed citations
11.
Atalay, Can, Ahmet Demirkazık, & Ufuk Gündüz. (2008). Role of ABCB1 and ABCC1 Gene Induction on Survival in Locally Advanced Breast Cancer. Journal of Chemotherapy. 20(6). 734–739. 17 indexed citations
12.
13.
14.
Demirkazık, Ahmet, et al.. (2004). Serum vascular endothelial growth factor levels in patients with non-small cell lung cancer. Annals of Saudi Medicine. 24(6). 473–475. 2 indexed citations
15.
Kavgacı, Halil, et al.. (2002). Respiratory Distress Due to Endotracheal Aspergilloma in an Immunocompromised Lymphoma Patient: Case Report. Journal of Chemotherapy. 14(1). 92–94. 5 indexed citations
16.
Demirkazık, Ahmet, Anne Kessinger, James Lynch, et al.. (2002). Effect of prior therapy and bone marrow metastases on progenitor cell content of blood stem cell harvests in breast cancer patients. Biology of Blood and Marrow Transplantation. 8(5). 268–272. 3 indexed citations
17.
İçlı, Fikri, et al.. (1999). Phase II Study of Cisplatin and Dacarbazine for Metastatic Colorectal Carcinoma Resistant to 5-Fluorouracil. Oncology. 56(4). 297–300. 5 indexed citations
18.
İçlı, Fikri, et al.. (1997). Phase II study of a modified combination of etoposide, doxorubicin, and cisplatin for patients with advanced gastric cancer. Journal of Surgical Oncology. 64(4). 318–323. 3 indexed citations
19.
20.
İçlı, Fikri, et al.. (1991). Treatment of metastatic malignant melanoma with 24 hours continuous venous infusion of dacarbazine and cisplatin. Journal of Surgical Oncology. 48(3). 199–201. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bicky Thapa Breakdown of academic impact, for papers by Claudia Rudroff Breakdown of academic impact, for papers by Kelley A. Barney Breakdown of academic impact, for papers by Konstantin Schlick Breakdown of academic impact, for papers by Patrícia Moretto Breakdown of academic impact, for papers by Mandeep S. Dhami Breakdown of academic impact, for papers by Scott Marshall Breakdown of academic impact, for papers by Abraham Klepfish Breakdown of academic impact, for papers by Elena Pérez‐Ceballos Breakdown of academic impact, for papers by Feras Abu Saadeh
Rankless by CCL
2026